Market Watch Highlights: Jazz Pharmaceuticals plc (JAZZ) Ends on an Downturn Note at 109.74

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

As of close of business last night, Jazz Pharmaceuticals plc’s stock clocked out at $109.74, down -2.03% from its previous closing price of $112.01. In other words, the price has decreased by -$2.03 from its previous closing price. On the day, 0.81 million shares were traded. JAZZ stock price reached its highest trading level at $113.055 during the session, while it also had its lowest trading level at $109.29.

Ratios:

To gain a deeper understanding of JAZZ’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.80 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.84. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 2.15. In the meantime, Its Debt-to-Equity ratio is 1.57 whereas as Long-Term Debt/Eq ratio is at 1.40.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on January 03, 2024, initiated with a Outperform rating and assigned the stock a target price of $160.

On November 27, 2023, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $170 to $135.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 03 ’24 when Patil Neena M sold 5,000 shares for $109.65 per share. The transaction valued at 548,250 led to the insider holds 36,629 shares of the business.

Carr Patricia sold 1,768 shares of JAZZ for $206,821 on Mar 07 ’24. The SVP, Chief Accounting Officer now owns 6,596 shares after completing the transaction at $116.98 per share. On Mar 06 ’24, another insider, Carr Patricia, who serves as the SVP, Chief Accounting Officer of the company, sold 1,936 shares for $119.64 each. As a result, the insider received 231,628 and left with 8,364 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAZZ now has a Market Capitalization of 6917965824 and an Enterprise Value of 10879542272. As of this moment, Jazz’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.87, and their Forward P/E ratio for the next fiscal year is 5.29. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.30. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.80 while its Price-to-Book (P/B) ratio in mrq is 1.87. Its current Enterprise Value per Revenue stands at 2.831 whereas that against EBITDA is 7.923.

Stock Price History:

The Beta on a monthly basis for JAZZ is 0.63, which has changed by -0.16705883 over the last 52 weeks, in comparison to a change of 0.2644323 over the same period for the S&P500. Over the past 52 weeks, JAZZ has reached a high of $146.70, while it has fallen to a 52-week low of $103.01. The 50-Day Moving Average of the stock is -4.26%, while the 200-Day Moving Average is calculated to be -11.78%.

Shares Statistics:

It appears that JAZZ traded 661.36K shares on average per day over the past three months and 723610 shares per day over the past ten days. A total of 62.26M shares are outstanding, with a floating share count of 60.94M. Insiders hold about 3.34% of the company’s shares, while institutions hold 98.14% stake in the company. Shares short for JAZZ as of 1714435200 were 3601103 with a Short Ratio of 5.45, compared to 1711584000 on 3263733. Therefore, it implies a Short% of Shares Outstanding of 3601103 and a Short% of Float of 7.5200000000000005.

Most Popular

[the_ad id="945"]